Breast Cancer Therapeutics Market Size By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centres, Clinics, e-commerce, Retail Pharmacies), Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Mar 2019  |  Report ID: GMI466  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 150   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Breast cancer therapeutics industry 3600 synopsis, 2014 - 2025 (USD Million)

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Distribution channel trends

2.1.4. Regional trends

Chapter 3. Breast Cancer Therapeutics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025 (USD Million)

3.3. Industry impact factors

3.3.1. Growth drivers

3.3.1.1. Increasing breast cancer prevalence in the developed countries

3.3.1.2. Advancements in cancer biology

3.3.1.3. Launch of several diagnostic and screening programs worldwide

3.3.1.4. Favorable insurance and reimbursement policies

3.3.2. Industry pitfalls & challenges

3.3.2.1. High cost of breast cancer therapeutics

3.4. Epidemiology landscape

3.4.1. U.S

3.4.2. Europe

3.5. Growth potential analysis

3.5.1. By product

3.5.2. By distribution channel

3.6. Pipeline analysis

3.7. Porter’s analysis

3.8. Company market share analysis, 2017

3.8.1. Strategy dashboard

3.9. PESTEL analysis

Chapter 4. Breast Cancer Therapeutics Market, By Product

4.1. Global breast cancer therapeutics market share by product, 2018 & 2025

4.2. Hormone drugs

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Chemotherapy drugs

4.3.1. Market size, by region, 2014 – 2025 (USD Million)

4.4. Targeted drug therapy

4.4.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 5. Breast cancer therapeutics Market, By Distribution channel

5.1. Global breast cancer therapeutics market share by distribution channel, 2018 & 2025

5.2. Hospitals

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Ambulatory Surgical Centers

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.4. Clinics

5.4.1. Market size, by region, 2014 – 2025 (USD Million)

5.5. e-commerce

5.5.1. Market size, by region, 2014 – 2025 (USD Million)

5.6. Retail pharmacies

5.6.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 6. Breast cancer therapeutics Market, By Region

6.1. Global breast cancer therapeutics market share by region, 2018 & 2025

6.2. North America

6.2.1. Market size, by country, 2014 – 2025 (USD Million)

6.2.2. Market size, by product, 2014 – 2025 (USD Million)

6.2.3. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.2.4. U.S.

6.2.4.1. Market size, by product, 2014 – 2025 (USD Million)

6.2.4.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.2.5. Canada

6.2.5.1. Market size, by product, 2014 – 2025 (USD Million)

6.2.5.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3. Europe

6.3.1. Market size, by country, 2014 – 2025 (USD Million)

6.3.2. Market size, by product, 2014 – 2025 (USD Million)

6.3.3. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.4. Germany

6.3.4.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.4.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.5. UK

6.3.5.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.5.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.6. France

6.3.6.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.6.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.7. Spain

6.3.7.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.7.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.8. Italy

6.3.8.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.8.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.9. Russia

6.3.9.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.9.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.3.10. Poland

6.3.10.1. Market size, by product, 2014 – 2025 (USD Million)

6.3.10.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4. Asia Pacific

6.4.1. Market size, by country, 2014 – 2025 (USD Million)

6.4.2. Market size, by product, 2014 – 2025 (USD Million)

6.4.3. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.4. China

6.4.4.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.4.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.5. Japan

6.4.5.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.5.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.6. India

6.4.6.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.6.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.7. South Korea

6.4.7.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.7.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.8. Australia

6.4.8.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.8.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.9. Malaysia

6.4.9.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.9.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.10. Indonesia

6.4.10.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.10.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.4.11. Thailand

6.4.11.1. Market size, by product, 2014 – 2025 (USD Million)

6.4.11.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.5. Latin America

6.5.1. Market size, by country, 2014 – 2025 (USD Million)

6.5.2. Market size, by product, 2014 – 2025 (USD Million)

6.5.3. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.5.4. Brazil

6.5.4.1. Market size, by product, 2014 – 2025 (USD Million)

6.5.4.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.5.5. Mexico

6.5.5.1. Market size, by product, 2014 – 2025 (USD Million)

6.5.5.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.5.6. Argentina

6.5.6.1. Market size, by product, 2014 – 2025 (USD Million)

6.5.6.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6. Middle East & Africa

6.6.1. Market size, by country, 2014 – 2025 (USD Million)

6.6.2. Market size, by product, 2014 – 2025 (USD Million)

6.6.3. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.4. South Africa

6.6.4.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.4.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.5. Saudi Arabia

6.6.5.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.5.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.6. UAE

6.6.6.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.6.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.7. Qatar

6.6.7.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.7.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.8. Kuwait

6.6.8.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.8.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

6.6.9. Egypt

6.6.9.1. Market size, by product, 2014 – 2025 (USD Million)

6.6.9.2. Market size, by distribution channel, 2014 – 2025 (USD Million)

Chapter 7. Company Profiles

7.1. AstraZeneca

7.1.1. Business overview

7.1.2. Financial data

7.1.3. Product landscape

7.1.4. Strategic outlook

7.1.5. SWOT analysis

7.2. Eisai Co., Ltd.

7.2.1. Business overview

7.2.2. Financial data

7.2.3. Product landscape

7.2.4. Strategic outlook

7.2.5. SWOT analysis

7.3. Eli Lilly

7.3.1. Business overview

7.3.2. Financial data

7.3.3. Product landscape

7.3.4. Strategic outlook

7.3.5. SWOT analysis

7.4. Roche Diagnostics

7.4.1. Business overview

7.4.2. Financial data

7.4.3. Product landscape

7.4.4. Strategic outlook

7.4.5. SWOT analysis

7.5. Novartis AG

7.5.1. Business overview

7.5.2. Financial data

7.5.3. Product landscape

7.5.4. Strategic outlook

7.5.5. SWOT analysis

7.6. Pfizer

7.6.1. Business overview

7.6.2. Financial data

7.6.3. Product landscape

7.6.4. Strategic outlook

7.6.5. SWOT analysis

7.7. Celgene

7.7.1. Business overview

7.7.2. Financial data

7.7.3. Product landscape

7.7.4. Strategic outlook

7.7.5. SWOT analysis

7.8. Sanofi

7.8.1. Business overview

7.8.2. Financial data

7.8.3. Product landscape

7.8.4. Strategic outlook

7.8.5. SWOT analysis

7.9. Teva Pharmaceutical

7.9.1. Business overview

7.9.2. Financial data

7.9.3. Product landscape

7.9.4. Strategic outlook

7.9.5. SWOT analysis
 

Data Tables

TABLE 1.    Breast cancer therapeutics industry 3600 synopsis, 2014 – 2025

TABLE 2.    Global breast cancer therapeutics market, 2014 – 2025 (USD Million)

TABLE 3.    Global breast cancer therapeutics market, by product, 2014-2025 (USD Million)

TABLE 4.    Global breast cancer therapeutics market, by distribution channel, 2014-2025 (USD Million)

TABLE 5.    Global breast cancer therapeutics market, by region, 2014-2025 (USD Million)

TABLE 6.    Industry impact forces

TABLE 7.    Breast cancer therapeutics pipeline overview

TABLE 8.    Hormone drugs market, by region, 2014 - 2025, (USD Million)

TABLE 9.    Chemotherapy drugs market, by region, 2014 - 2025, (USD Million)

TABLE 10.    Targeted drug therapy market, by region, 2014 - 2025, (USD Million)

TABLE 11.    Hospitals market, by region, 2014 - 2025, (USD Million)

TABLE 12.    Ambulatory surgical centers market, by region, 2014 - 2025, (USD Million)

TABLE 13.    Clinics market, by region, 2014 - 2025, (USD Million)

TABLE 14.    e-commerce market, by region, 2014 - 2025, (USD Million)

TABLE 15.    Retail pharmacies market, by region, 2014 - 2025, (USD Million)

TABLE 16.    North America breast cancer therapeutics market, by country 2014 - 2025 (USD Million)

TABLE 17.    North America breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 18.    North America breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 19.    U.S. breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 20.    U.S. breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 21.    Canada breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 22.    Canada breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 23.    Europe breast cancer therapeutics market, by country 2014 - 2025 (USD Million)

TABLE 24.    Europe breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 25.    Europe breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 26.    Germany breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 27.    Germany breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 28.    UK breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 29.    UK breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 30.    France breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 31.    France breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 32.    Spain breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 33.    Spain breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 34.    Italy breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 35.    Italy breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 36.    Russia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 37.    Russia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 38.    Poland breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 39.    Poland breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 40.    Asia Pacific Breast Cancer Therapeutics market, by country 2014 - 2025 (USD Million)

TABLE 41.    Asia Pacific breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 42.    Asia Pacific breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 43.    Japan breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 44.    Japan breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 45.    China breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 46.    China breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 47.    India breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 48.    India breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 49.    Australia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 50.    Australia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 51.    Malaysia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 52.    Malaysia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 53.    Indonesia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 54.    Indonesia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 55.    Thailand breast cancer therapeutics market, by product, 2014 - 2025 (USD Million) 

TABLE 56.    Thailand breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 57.    Latin America Breast Cancer Therapeutics market, by country 2014 - 2025 (USD Million)

TABLE 58.    Latin America breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 59.    Latin America breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 60.    Mexico breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 61.    Mexico breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 62.    Brazil breast cancer therapeutics market, by product, 2014 - 2025 (USD Million) 

TABLE 63.    Brazil breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 64.    Argentina breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 65.    Argentina breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 66.    MEA breast cancer therapeutics market, by country 2014 - 2025 (USD Million)

TABLE 67.    MEA breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 68.    MEA breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 69.    South Africa breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 70.    South Africa breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 71.    UAE breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 72.    UAE breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 73.    Qatar breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 74.    Qatar breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 75.    Saudi Arabia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)

TABLE 76.    Saudi Arabia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 77.    Kuwait breast cancer therapeutics market, by product, 2014 - 2025 (USD Million) 

TABLE 78.    Kuwait breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

TABLE 79.    Egypt breast cancer therapeutics market, by product, 2014 - 2025 (USD Million) 

TABLE 80.    Egypt breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global breast cancer therapeutics market, 2014- 2025 (USD Million)

FIG. 3    Age adjusted female breast cancer incidence rates, U.S., 2004 & 2014

FIG. 4    Growth potential analysis, by product

FIG. 5    Growth potential analysis, by distribution channel

FIG. 6    Porter’s analysis

FIG. 7    Company share analysis, 2017

FIG. 8    Strategic dashboard, 2017

FIG. 9    PESTEL analysis

FIG. 10    Breast cancer therapeutics market share by product, 2018 & 2025

FIG. 11    Breast cancer therapeutics market share by distribution channel, 2018 & 2025

FIG. 12    Breast cancer therapeutics market share, by region, 2018 & 2025

   

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Mar 2019
  • Pages: 150
  • Tables: 80
  • Charts / Figures: 12
  • Companies covered: 9
  • Countries covered: 26

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X